Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas

Cancer Investigation

Volumn 20, Issue 5-6, 2002, Pages 605-612

  Edmonson, John H ^a   Marks, Randolph S ^a   Buckner, Jan C ^a   Mahoney, Michelle R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chemotherapy; Gastrointestinal stromal tumor; Granulocyte macrophage colony stimulating factor; Leiomyosarcoma; Ovarian sarcoma; Soft tissue sarcoma

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; DACARBAZINE; DOXORUBICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; MITOMYCIN; ANTINEOPLASTIC AGENT; DMAP PROTOCOL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLON; CYTOTOXICITY; DRUG RESPONSE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOLOGY; HUMAN; LEIOMYOSARCOMA; LEUKOPENIA; LUNG TOXICITY; MALE; PANCREAS; PRIORITY JOURNAL; SMALL INTESTINE; SOFT TISSUE SARCOMA; STOMACH; THROMBOCYTOPENIA; TUMOR REGRESSION; UTERUS SARCOMA; VOMITING; CLINICAL TRIAL; GASTROINTESTINAL TUMOR; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; SURVIVAL; TREATMENT OUTCOME; UTERUS CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DACARBAZINE; DOXORUBICIN; FEMALE; GASTROINTESTINAL NEOPLASMS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFUSIONS, INTRAVENOUS; LEIOMYOSARCOMA; MALE; MIDDLE AGED; MITOMYCIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 0036049018     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120002485     Document Type: Article

References (21)

1. Borden, E,C.; Amato, D.A.; Rosenbaum, C.; Enterline, H.T.; Shiraki, M.J. ; Creech, R.H.; Lerner, H.J.; Carbone, P. Randomized Comparison of Three Adriamycin Regimens for Metastatic Soft Tissue Sarcomas. J. Clin. Oncol. 1987, 5, 840-850.
2. Edmonson, J.H.; Ryan, L.M.; Blum, R.H.; Brooks, J.S.J.; Shiraki, M.; Parkinson, D.R. Randomized Comparison of Doxorubicin Alone Versus Ifosfamide + Doxorubicin or Mitomycin + Doxorubicin + Cisplatin Against Advanced Soft Tissue Sarcomas. J. Clin. Oncol. 1993, 11, 1269-1275.
3. Zalupski, M.; Metch, B.; Balcerzak, S.; Fletcher, W.S.; Chapman, R.; Bonnet, J.D.; Weiss, G.R.; Ryan, J.; Benjamin, R.S.; Baker, L.H. Phase III Comparison of Doxorubicin and Dacarbazine Given by Bolus Versus Infusion in Patients with Soft-Tissue Sarcomas: A Southwest Oncology Group Study. J. Natl Cancer Inst. 1991, 83, 926-932.
4. Lerner, H.; Amato, D.; Stevens, C.; Border, E.; Enterline, H. Leiomyosarcoma: The Eastern Cooperative Oncology Group Experience with 222 Patients. Proc. Am. Assoc. Cancer Res. 1983, 142.
5. Edmonson, J.H.; Hartmann, L.C.; Long, H.J.; Colon-Otero, G.; Fitch, T.R. ; Jefferies, J.A.; Braich, T.A.; Maples, W.J. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF): Preliminary Observations on the Influences of Dose, Schedule, and Route of Administration in Patients Receiving Cyclophosphamide Plus Carboplatin. Cancer 1992, 70, 2529-2539.
6. Dispenzieri, A.; Loprinzi, C. Chemotherapy-Induced Insulin Dependent Diabetes Mellitus. J. Clin. Oncol. 1997, 15, 1287.
7. Sircar, K.; Hewlett, B.R.; Huizinga, J.D.; Chorneyko, K.; Barezin, I.; Riddell, R.H. Interstitial Cells of Cajal as Precursors of Gastrointestinal Stromal Tumors. Am. J. Surg. Pathol. 1999, 23, 377-389.
8. Plaat, B.E.C.; Hollema, H.; Molenaar, W.M.; Torn Broers, G.H.; Pijpe, J; Mastik, M.F.; Hoekstra, H.J.; van den Berg, E.; Scheper, R.J.; van der Graaf, W.T.A. Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins. J. Clin. Oncol. 2000, 18, 3211-3220.
9. Omura, G.A.; Major, F.J.; Blessing, J.A.; Sedlocek, T.V.; Thigpen, J.T.; Creasman, W.T.; Zaino, R.J. A Randomized Study of Adriamycin with and without Dimethyl Triazenoimidazole Carboxamide in Advanced Uterine Sarcomas. Cancer 1983, 52, 626-632.
10. Muss, H.B.; Bundy, B.; DiSaia, P.J.; Homesley, H.D.; Fowler, W.C.; Creasman, W.; Yordan, E. Treatment of Recurrent or Advanced Uterine Sarcoma. A Randomized Trial of Doxorubicin Versus Doxorubicin and Cyclophosphamide (A Phase III Trial of the Gynecologic Oncology Group). Cancer 1985, 55, 1648-1653.
11. Thigpen, J.T.; Blessing, J.A.; Beecham, J.; Homeley, H.; Yordan, E. Phase II Trial of Cisplatin as First-Line Chemotherapy in Patients with Advanced or Recurrent Uterine Sarcomas: A Gynecologic Oncology Group Study. J. Clin. Oncol. 1991, 9, 1962-1966.
12. Sutton, G.P.; Blessing, J.A.; Barrett, R.J.; McGhee, R. Phase II Trial of Ifosfamide and Mesna in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study. Am. J. Obstet. Gynecol. 1992, 166, 556-559.
13. Sutton, G.; Blessing, J.A.; Malfetano, J.H. Ifosfamide and Doxorubicin in the Treatment of Advanced Leiomyosarcomas of the Uterus: A Gynecologic Oncology Group Study. Gynecol. Oncol. 1996, 62, 226-229.
14. Slayton, R.E.; Blessing, J.A.; Angel, C.; Berman, M. Phase II Trial of Etoposide in the Management of Advanced Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study. Cancer Treat. Rep. 1987, 71, 1303-1304.
15. Thigpen, T.; Blessing, J.A.; Yordan, E.; Valea, F.; Vaccarello, L. Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study. Gynecol. Oncol. 1996, 63, 120-122.
16. Rose, P.G.; Blessing, J.A.; Soper, J.T.; Barter, J.F. Prolonged Oral Etoposide in Recurrent or Advanced Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study. Gynecol. Oncol. 1998, 70, 267-271.
17. Muss, H.B.; Bundy, B.N.; Adcock, L.; Beecham, J. Mitoxantrone in the Treatment of Advanced Uterine Sarcoma. Am. J. Clin. Oncol. 1990, 13, 32-34.
18. Slayton, R.E.; Blessing, J.A.; Look, K.; Anderson, B. A Phase II Clinical Trial of Diaziquone (AZQ) in the Treatment of Patients with Recurrent Leiomyosarcoma of the Uterus (A Gynecologic Oncology Group Study). Invest. N. Drugs 1991, 9, 207-208.
19. Asbury, R.; Blessing, J.A.; Smith, D.; Carson, L.F. Aminothiadiazole in the Treatment of Patients with Metastatic Leiomyosarcoma of the Uterine Corpus: A Gynecologic Oncology Group Study. Am. J. Clin. Oncol. 1995, 18, 397-399.
20. Asbury, R.; Blessing, J.A.; Buller, R.; Malfetano, J.H.; Walker, J.; Sevin, B.U. Amonafide in Patients with Leiomyosarcoma of the Uterus: A Phase II Gynecologic Oncology Group Study. Am. J. Clin. Oncol. 1998, 21, 145-146.
21. Currie, J.L.; Blessing, J.A.; Muss, H.B.; Fowler, J.; Berman, M.; Burke, T.W. Combination Chemotherapy with Hydroxyurea, Dacarbazine (DTIC), and Etoposide in the Treatment of Uterine Leiomyosarcoma: A Gynecologic Oncology Group Study. Gynecol. Oncol. 1996, 61, 27-30.